Distinction between anti-VGKC-complex seropositive patients with and without anti-LGI1/CASPR2 antibodies

To identify clinical and paraclinical differences between anti-voltage-gated potassium channel (VGKC)-complex seropositive patients with and without anti-leucine-rich glioma-inactivated protein 1 (LGI1)/contactin-associated protein-like 2 (CASPR2) antibodies (Abs).

Source: Journal of the Neurological Sciences - May 27, 2018 Category: Neurology Authors: Tianrong Yeo, Zhiyong Chen, Kok Pin Yong, Patricia Yut Wan Wong, Josiah Yui Huei Chai, Kevin Tan Source Type: research